Brown, W., & Coles, A. (2013). Alemtuzumab: Evidence for its potential in relapsing-remitting multiple sclerosis. Drug design, development and therapy, 7, 131-138. https://doi.org/10.2147/DDDT.S32687
Citace podle Chicago (17th ed.)Brown, William, a Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy 7 (2013): 131-138. https://doi.org/10.2147/DDDT.S32687.
Citace podle MLA (9th ed.)Brown, William, a Alasdair Coles. "Alemtuzumab: Evidence for Its Potential in Relapsing-remitting Multiple Sclerosis." Drug Design, Development and Therapy, vol. 7, 2013, pp. 131-138, https://doi.org/10.2147/DDDT.S32687.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..